September 4, 2026 · earnings
ENLV earnings: a negative outcome, -5.2%
On September 4, 2026, Enlivex Therapeutics Ltd. reached its earnings. The result was a negative outcome, and the stock moved -5.2% in the window around the event. It had already run -41.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$1.16
1d before
$1.10
Event day
$1.10
1d after
$1.04
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+0.6% expected); the stock actually moved -5.2%. Model confidence at the time: 40%.
See the full scored track recordPre-catalyst setup
-41.3%
30-day run-up
8913%
30-day volatility
1.0×
volume spike